免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

酶填充弹匣 - RELiZORB

K号: K231156 · 2023-08-30

决定日期2023-08-30
产品代码PLQ
咨询委员会GU 请注意,由于您只提供了“GU”这个词,我无法提供完整的翻译。如果您能提供完整的句子或段落,我将能够为您提供准确的翻译。
决定实质等同

器械摘要

Enzyme Packed Cartridge - RELiZORB is the device name listed in this FDA 510(k) record. The listed applicant is Alcresta Therapeutics, Inc.. It received FDA 510(k) clearance on 2023-08-30 under 510(k) number K231156. The device is classified under product code PLQ. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Enzyme Packed Cartridge - RELiZORB?

Enzyme Packed Cartridge - RELiZORB is a medical device that received FDA 510(k) clearance on 2023-08-30. The listed applicant is Alcresta Therapeutics, Inc.. The 510(k) number is K231156.

When did Enzyme Packed Cartridge - RELiZORB receive FDA 510(k) clearance?

Enzyme Packed Cartridge - RELiZORB received FDA 510(k) clearance on 2023-08-30, under 510(k) number K231156.

Who is the listed applicant for Enzyme Packed Cartridge - RELiZORB?

The FDA 510(k) record lists Alcresta Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Enzyme Packed Cartridge - RELiZORB?

The FDA product code for Enzyme Packed Cartridge - RELiZORB is PLQ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Alcresta Therapeutics, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 7 个设备 →

相关器械(代码:PLQ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑